Press Releases
Teck Announces Commencement of Consent Solicitation
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (the “Company”) announced today the commencement of consent solicitations (each, a “Consent Solicitation” and, together, the “Consent Solicitations”) relating to its outstanding U.S. $142,236,000 aggregate principal amount of 3.900% notes due July 15, 2030 (the “2030 Notes”), its outstanding U.S. $179,456,000 aggregate principal amount of 6.125% notes due October 1, 2035 (the “2035 Notes”), its outstanding U.S. $189,908,000 aggregate principal amount of 6.000% notes due August 15, 2040 (the “2040 Notes”), its outstanding U.S. $242,528,000 aggregate principal amount of 6.250% notes due July 15, 2041 (the “2041 Notes”), its outstanding U.S. $166,862,000 aggregate principal amount of 5.200% notes due March 1, 2042 (the “2042 Notes”), and its outstanding U.S. $107,958,000 aggregate principal amount of 5.400% notes due February 1, 2043 (the “2043 Notes” and, together with the 2030 Notes, the 2035 Notes, the 2040 Notes, the 2041 Notes and the 2042 Notes, the “Affected Notes” and, together with any other notes issued from time to time under each relevant indenture, the “Notes”)...
Realty Income Receives 'A' Credit Rating from Fitch Ratings
SAN DIEGO, Aug. 3, 2026 /PRNewswire/ -- Realty Income Corporation (Realty Income) (NYSE: O) (the "Company"), The Monthly Dividend Company, today announced that Fitch Ratings ("Fitch") has assigned the Company a Long-Term Issuer Default Rating of 'A' with a Stable Outlook. This rating makes Realty Income the first net lease REIT and only the fourth U.S. REIT to have at least one 'A' or equivalent rating from one of the three major rating agencies...
CACI Names Marcie Small Executive Vice President and Chief Human Resources Officer
RESTON, Va., Aug. 3, 2026 /PRNewswire/ -- CACI International Inc (NYSE: CACI) announced today that Marcie Small has been appointed Executive Vice President and Chief Human Resources Officer.
Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Greg Raskin, M.D. as Senior Vice President, Head of Academic Initiatives, effective August 2026. Greg will lead Royalty Pharma's outreach efforts with academic and non-profit institutions as well as oversee the Royalty Pharma Translational Prize. Greg joins Royalty Pharma after nearly three decades at the intersection of science, medicine and investing, and most recently served as Senior Vice President, Technology Development at Memorial Sloan Kettering Cancer Center...
Alpha Cash Introduces First Super Connector Ecosystem, Launching a New Model for Community-Based Financial Access
CORNELIUS, N.C., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Alpha Cash, the mobile financial services platform operated by Alpha Modus Financial Services, LLC, a wholly owned subsidiary of Alpha Modus Holdings, Inc. (NASDAQ: AMOD), today announced the launch of its first “Super Connector” ecosystem, introducing a new community-driven model for expanding financial access through trusted local organizations rather than traditional banking infrastructure...
Edible Garden Secures Multi-Year Private Label Supply Agreement, Expanding Partnership with Major Midwest Big-Box Retailer
Agreement Broadens Private Label Herb Program Across the Midwest and Further Strengthens Long-Term Retail Growth Strategy Agreement Broadens Private Label Herb Program Across the Midwest and Further Strengthens Long-Term Retail Growth Strategy
Northrop Grumman Enters Into $3 Billion Landmark Agreements to Accelerate Missile Interceptor Production
Multi-year framework agreements with the U.S. Department of War and Lockheed Martin deliver speed, scale and certainty for the United States and allies Multi-year framework agreements with the U.S. Department of War and Lockheed Martin deliver speed, scale and certainty for the United States and allies
Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
NEEDHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that an abstract was accepted for poster presentation at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, taking place September 26-30, 2026, in Boston, MA...
Diebold Nixdorf Recognized as an Android™ Enterprise Gold Partner
Recognition advances reliable, enterprise-scale Android deployments for customers with enhanced support and faster rollout capabilities NORTH CANTON, Ohio, Aug. 3, 2026 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD), a world leader in transforming the way people bank and shop, has been validated by Android Enterprise as an Android Enterprise Gold Partner, the company's highest status for delivering and supporting enterprise-scale Android solutions. This validates Diebold Nixdorf's deep expertise in Android-based enterprise mobile solutions and reinforces its strategic direction as a hardware-agnostic mobile advisor...
EXL completes acquisition of iMerit, accelerating enterprise AI leadership
iMerit founder and CEO Radha Ramaswami Basu joins EXL executive committee iMerit founder and CEO Radha Ramaswami Basu joins EXL executive committee
Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
Vancouver, Canada, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation psychedelic, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that it has entered into a non-binding Letter of Intent (“LOI”) to acquire 51% stake in a leading intelligent EV (electric vehicles) wireless charging solutions for automated parking systems and autonomous mobile platforms company (the “Acquired Company”)...
VENU Secures $25 Million in Debt Financing, Fueling Regent Bank Amphitheater's Path to Fall 2026 Opening
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)---- $VENU #CPACE--Venu Holding Corporation ("VENU" or the “Company”) (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today announced it has closed on a $25 million financing transaction. The funds are dedicated to the construction costs for the Company's premium 12,500-seat entertainment destination, Regent Bank Amphitheater in Broken Arrow, just outside of Tulsa, Oklahoma, set to be complete this coming fall 2026. The...
POET Technologies Appoints Dr. Bardia Pezeshki and Jean F. Rankin to Board of Directors as Long-serving Director, Jean-Louis Malinge Resigns
TORONTO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced the appointments of Dr. Bardia Pezeshki and Jean F. Rankin to its Board of Directors, effective August 1, 2026...
AGCO Aligns Leadership to Advance PTx™ Growth Strategy
Damon Audia to lead PTx & Corporate Strategy; Indira Agarwal appointed Senior Vice President, Chief Financial Officer DULUTH, Ga., Aug. 3, 2026 /PRNewswire/ -- AGCO Corporation (NYSE: AGCO) today announced a series of executive leadership changes effective August 1, 2026.
NextPlat to Release Second Quarter 2026 Results on Thursday, August 13, 2026
Investor Conference Call Scheduled for Thursday, August 13, 2026 at 8:30 a.m. Eastern HALLANDALE BEACH, Fla.
Neuronetics and Jorey Chernett Announce Shared Vision
MALVERN, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics” or the “Company”) and Jorey Chernett, the Company's second largest shareholder and Managing Member of Pointillist Family Office, today announced that they have created a constructive framework for alignment between the Company's Board of Directors (the “Board”), management, and Mr. Chernett (the “Understanding”)...
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation
Nominates Two New Independent Directors, Mr. Gautam Patel and Dr. Adrian Senderowicz, Who Bring Deep, Relevant Experience in Life Sciences
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter (“1Q27”) ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also hold its first earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts...
From AI Prompts to Perfect Property Placement: Phillips Edison & Company Makes Site Selection Smarter
PECO Announces Launch of New AI-Integrated Website with Enhanced Search Capability, Marking a First for the Shopping Center REIT Sector PECO Announces Launch of New AI-Integrated Website with Enhanced Search Capability, Marking a First for the Shopping Center REIT Sector
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
Centers for Medicare & Medicaid Services (CMS) Fiscal Year 2027 Inpatient Final Rule creates three new Medicare Severity-Diagnosis Related Groups (MS-DRGs), with favorable reimbursement for Carlsmed aprevo Lumbar spine fusion procedures Centers for Medicare & Medicaid Services (CMS) Fiscal Year 2027 Inpatient Final Rule creates three new Medicare Severity-Diagnosis Related Groups (MS-DRGs), with favorable reimbursement for Carlsmed aprevo Lumbar spine fusion procedures
Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the initiation of a Phase 2 basket trial to evaluate the safety, efficacy, and pharmacokinetics of ebribafusp for the treatment of rare complement-mediated kidney diseases, including IgA nephropathy (IgAN), lupus nephritis (LN), and C3 glomerulopathy (C3G)...
Unhappy With The $14.25 Per Share Buyout Price? Contact Kaskela Law to Discuss Your Legal Rights and Options with Respect to the Buyout - UTZ
PHILADELPHIA, Aug. 3, 2026 /PRNewswire/ -- Litigation firm Kaskela Law is investigating the sufficiency of the Utz Brands, Inc. (NYSE: UTZ) ("Utz") shareholder buyout proposal to determine whether Utz stockholders may be able to obtain a higher price for their shares. Additional information available at: https://kaskelalaw.com/case/utz-buyout/ On July 21, 2026, Utz reported that it had agreed to be acquired by European snack manufacturer Intersnack Group GmbH & Co. KG ("Intersnack") at a price of $14.25 per share in cash...
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the appointment of Alejandra Carvajal as Chief Legal Officer.
Petco Appoints Jeffrey Naylor to Board of Directors
Former CFO of The TJX Companies, Inc. and retail veteran to serve as Audit Committee Chair, bringing deep financial and operational expertise to further support Petco's strategic initiatives SAN DIEGO, Aug. 3, 2026 /PRNewswire/ -- Petco Health & Wellness Company, Inc. (Nasdaq: WOOF) today announced the appointment of Jeffrey Naylor, former Chief Financial Officer of TJX Companies, to its Board of Directors, effective August 1, 2026. In addition to his role on the Board, Mr...
eGain Points to AI KnowledgeOps as Key to AI Governance at Ai4 2026
SUNNYVALE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the AI knowledge platform company and a Leader in the inaugural Gartner Magic Quadrant™ for Customer Service Knowledge Management Systems, will exhibit at Ai4 2026, August 4 to 6 at The Venetian in Las Vegas.
EagleNXT Names Head of Sales and Business Development for Counter-UAS
21-Year Army Aviation Veteran Named Head of C-UAS Sales and Business Development for EagleNXT ALLEN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems, Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of full-stack drone, sensor, counter-UAS, and software solutions for defense, government, and commercial applications worldwide, today announced the appointment of Lindsay A. Ryan as Head of Sales and Business Development for EagleNXT Counter-UAS systems...
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
Anchoring Established Healthcare Operations to Technology-Enabled Growth Opportunities GUANGZHOU, China, Aug. 3, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today highlighted its four-tier diversified revenue structure, which is designed to build on the Company's established healthcare operations while developing scalable, technology-enabled services. The Company's four-tier revenue structure consists of B2C basic healthcare services, AI-enabled chronic disease membership subscriptions, B2B enterprise and hospital services, along with pharmaceutical real-world study ("RWS") and real-world data ("RWD") services...
Harris Teeter Launches New Prescription Delivery Options
MATTHEWS, N.C., Aug. 3, 2026 /PRNewswire/ -- Harris Teeter announced today that customers can now receive prescriptions and groceries together powered by Instacart, expanding its delivery services to offer more convenient ways to receive eligible prescriptions.
Marcus & Millichap Declares Regular Semi-Annual Dividend of $0.25 Per Share
CALABASAS, Calif.--(BUSINESS WIRE)--Marcus & Millichap Inc. (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today that its Board of Directors has declared a regular semi-annual dividend of $0.25 per share, or approximately $10.0 million. The dividend will be payable on October 6, 2026, to shareholders of record as of the close of business on September 15, 2026. Any and all future dividends ar...
Griffon Corporation Announces Closing of AMES Australasia Transaction
NEW YORK--(BUSINESS WIRE)--Griffon Corporation (NYSE: GFF) (the “Company” or “Griffon”) today announced the closing of the joint venture between Griffon's AMES Australasia business and an investment group led by the management of AMES Australasia with support from Australian financial investors. Griffon received $181 million in cash, a $49 million paid-in-kind (PIK) note receivable from the joint venture, and a 49% equity interest. Goldman Sachs & Co. LLC acted as financial advisor to Griff...
Sonida Senior Living Announces Second Quarter Earnings Release Date and Conference Call
DALLAS--(BUSINESS WIRE)--Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in communities and services for seniors, announced today that it will issue its second quarter 2026 earnings results before the market opens for trading on Monday, August 10, 2026. The Company will then host a conference call and webcast to review its financial performance and operating results at 11:00 a.m. Eastern Time. The dial-in number for the conference call...
LogProstyle Celebrates 20th Anniversary of Founding
TOKYO--(BUSINESS WIRE)--LogProstyle Inc. (NYSE American: LGPS) (the “Company” or “LogProstyle”), headquartered in Minato-ku, Tokyo, Japan, announced today that the Company and its group companies celebrated the 20th anniversary of their founding on August 1, 2026. Yasuyuki Nozawa, Representative Director, President and CEO of LogProstyle, commented: “We are pleased to have celebrated the 20th anniversary of our group's founding on August 1, 2026. On behalf of our entire team, I would like to ex...
Freedom Metals Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 4, 2026
Miami, FL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Freedom Metals Acquisition Corp. (Nasdaq: FDMMU) (the “Company”) announced today that, commencing August 4, 2026, the holders of the units issued in the Company's initial public offering (the “Units”), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade...
GSI Technology to Participate in Needham Virtual Semiconductor & SemiCap Conference on August 19, 2026
SUNNYVALE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute processing, providing true compute-in-memory technology, today announced that it will participate in the Needham Virtual Semiconductor & SemiCap Conference, to be held virtually on August 19-20, 2026...
Carver Bancorp, Inc. Announces Agreement with EJF Capital to Cancel Interest in Exchange for Shares of Common Stock
Exchange Agreement Follows Prior $1 Million-Plus Interest Cancellation and Demonstrates Institutional Investor's Belief in Carver's Value-Creation Potential NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Carver Bancorp, Inc. ("Carver" or the "Company") (OTCQB: CARV), the holding company for Carver Federal Savings Bank (the "Bank"), today announced that it has entered into a second agreement with EJF Capital LP ("EJF"), whose affiliates hold the Company's Trust Preferred Securities (the "TruPS") and have agreed to cancel approximately $250,000 in interest obligations in exchange for 100,174 shares of Carver common stock (the "Exchange Agreement"). This Exchange Agreement follows the previously announced cancellation of more than $1 million in interest obligations by TruPS holder EJF...
Powerus Awarded U.S. Air Force IDIQ Contract Up to $90 Million for Aerial Denial
Competitively awarded indefinite-delivery/indefinite-quantity contract has a ceiling of up to $90 million and runs through mid-2028 Powerus has announced a proposed merger with Aureus Greenway Holdings Inc. (Nasdaq: PUSA); the merger has not closed and remains subject to customary closing conditions, including the effectiveness of a Form S-4 registration statement and applicable regulatory approvals WEST PALM BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Autonomous Power Corporation, doing business as “Powerus,” today announced that its wholly owned subsidiary, Tandem Defense LLC, has been awarded a competitively bid contract by the U.S. Air Force for Group 1 aerial-denial unmanned aircraft systems, with a maximum value of $90 million over the life of the award...
RTX's Raytheon completes installation of first SPY-6(V)4 array at Wallops Island test site
New radar testing will support U.S. Navy Destroyer modernization efforts WALLOPS ISLAND, Va., Aug. 3, 2026 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, has delivered and installed the first SPY-6(V)4 radar array at Surface Combat Systems Center at Wallops Island in Virginia, marking a major milestone for the U.S. Navy's Flight IIA Destroyer modernization effort and the SPY-6 backfit program...
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
CAMBRIDGE, Mass. and DALLAS and TAMPA, Fla.
Local Bounti to Release Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
HAMILTON, Mont., Aug. 3, 2026 /PRNewswire/ -- Local Bounti Corporation (NYSE: LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S. indoor agriculture company, today announced it will release its financial results for the fiscal second quarter ended June 30, 2026, before the market opens on Wednesday, August 12, 2026...
Arbe to Present at Canaccord Genuity's 46th Annual Growth Conference
TEL AVIV, Israel, Aug. 3, 2026 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE), a global leader in ultra-high-resolution radar solutions, today announced that Kobi Marenko, President, will present at and meet with investors during Canaccord Genuity's 46th Annual Growth Conference, taking place at the InterContinental in Boston on August 11-13, 2026...
Swarmer and Oak Grove Technologies Announce Strategic Partnership to Advance Autonomous Drone Swarming Capabilities for U.S. Special Operations
Swarmer's battle-tested software has been integrated aboard Oak Grove's Chimera UAVs and tested extensively during recent test flights in Eastern Europe Swarmer's battle-tested software has been integrated aboard Oak Grove's Chimera UAVs and tested extensively during recent test flights in Eastern Europe
electroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., Aug. 03, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences:
Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results
RESTORE-FA trial modifications build on positive four-week data; expect to share data based on 12 weeks of dosing in the first quarter of 2027 Patient dosing initiated in Phase 1 multiple-ascending dose trial of DT-818 in myotonic dystrophy type 1 Cash and securities of $207.4 million at quarter-end provide strong financial runway CARLSBAD, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported second quarter 2026 financial results and highlighted business updates and upcoming milestones across its GeneTAC portfolio...
The Oncology Institute Rebrands as Starling Oncology
CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or “the Company”), one of the largest value-based oncology groups in the United States, announced today that it has rebranded to “Starling Oncology, Inc.™.
KellyOCG® Named Global and U.S. Leader in Everest Group's 2026 RPO PEAK Matrix®
Recognition reflects strengths of scalable recruitment process outsourcing solutions supported by AI-powered technology and consulting services Facts at a Glance: KellyOCG's recruitment process outsourcing (RPO) business serves clients in more than 70 countries and 30 languages, with a 98% client retention rate. The integration of KellyOCG, RocketPower™ and Sevenstep services has unlocked agile delivery of modular and enterprise-scale RPO solutions...
Cohen & Company Reports Second Quarter 2026 Financial Results
Board Declares Quarterly Dividend of $0.25 per Share Revenue of $69.5 Million Net Income Attributable to Cohen & Company Inc. of $3.6 Million, or $0.94 per Diluted Share Adjusted Pre-Tax Income of $10.1 Million, or $1.62 per Diluted Share PHILADELPHIA and NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN) (“Cohen & Company” or the “Company”) today reported financial results for its second quarter ended June 30, 2026. Lester Brafman, Chief Executive Officer of Cohen & Company, said, “We are pleased to deliver another solid quarter, driven by continued strong performance in our full-service boutique investment bank, Cohen & Company Capital Markets, and its expertise in SPAC and de-SPAC transactions...
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH
Global registrational study designed to evaluate pemvidutide on fibrosis improvement, MASH resolution, and clinical outcomes
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
DURHAM, N.C., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced it will report second quarter 2026 financial results on Thursday, August 13, 2026...
Shoals Technologies Group and TerraFlow Energy Forge Multi-Gigawatt Partnership to Advance the Future of Energy Storage
PORTLAND, Tenn., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced a strategic Memorandum of Understanding (MOU) with TerraFlow Energy, grid-scale, long-duration energy storage infrastructure...
Survey: Nearly 9 in 10 agents believe buyers benefit from independent representation, access to every listing
New Zillow survey finds agents overwhelmingly agree on what's best for buyers, even as financial incentives drive some in the industry to push private listing networks that work against it. 88% of agents say independent representation is in a buyer's interest — but 39% report that they don't see how it benefits agents, revealing the financial incentive behind practices like private listing networks 86% of agents say buyers deserve access to every listing on the market, yet nearly 1 in 3 don't believe that same access benefits agents Previous Zillow research found that sellers who sold to a buyer using the same agent lost a combined $1.49 billion over three years — an average loss of roughly $2,165 per home SEATTLE, Aug. 3, 2026 /PRNewswire/ -- A new Zillow survey shows that real estate agents, by and large, agree that independent representation, access to every available listing and the ability to choose whether to hire an agent are all good for buyers...
Vision Marine Technologies Advances European E-Motion™ Integration Program with STERK Yachts
Summer program will integrate and evaluate Vision Marine's E-Motion™ 180E propulsion system aboard the STERK 26E in European boating environments. BOISBRIAND, QC, Aug. 3, 2026 /PRNewswire/ -- Vision Marine Technologies Inc. (NASDAQ: VMAR; TSXV: VMAR) ("Vision Marine" or the "Company"), a marine technology and recreational boating company, today announced plans to begin the integration and on-water evaluation of its E-Motion™ 180E high-voltage electric propulsion system aboard the STERK 26E in Europe during summer 2026...
Aspida Life and Market Synergy Group Launch T. Rowe Price U.S. Equity 15 Index in Synergy Choice™ FIA Suite
DURHAM, NC, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Aspida Life Insurance Company (“Aspida Life”), a life insurance and annuity company, in partnership with Market Synergy Group (MSG) and T. Rowe Price, has announced the addition of the T.
KnowBe4 Extends Agent Security to Anthropic's Claude With Agent Risk Manager
LAS VEGAS--(BUSINESS WIRE)--Black Hat Conference - KnowBe4, the global leader in digital workforce security, securing both AI agents and humans, today announced Agent Risk Manager support for Anthropic's Claude. KnowBe4 now extends its agent governance layer to Claude environments, building on existing native support for Microsoft Copilot. With agentic AI widely integrated into daily work, 58% of cybersecurity leaders from the KnowBe4 2026 Agentic Risk to Human Wins Report state that AI agents...
CrowdStrike Fal.Con 2026 Sells Out at Record Pace as the Industry Races to Secure AI
AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced that Fal.Con 2026 has sold out, reaching capacity faster than any previous year. The surge in demand reflects a new reality: the more AI organizations adopt, the more cybersecurity they require. Fal.Con brings together the world's top defenders, innovators, and researchers to define how the industry secures the agentic era on the CrowdStrike Falcon platform. From August 31 – September 3, more than 10,000 attendees and 4...
Thales Launches Imperva for AWS to Help Organizations Protect Applications and APIs
MEUDON, France--(BUSINESS WIRE)--Thales today announced the availability of Imperva for AWS, bringing its industry-leading web application firewall (WAF) to Amazon Web Services, Inc. (AWS) Marketplace as a SaaS offering. Built on key AWS services, Imperva for AWS helps organizations protect web applications and APIs against common cyber threats and malicious bot activity. The 2026 Thales Bad Bot Report found that automated traffic now accounts for 53% of all internet requests, with 27% of bot a...
Jonathan ("JD") Dale Appointed Avidbank President
SAN JOSE, CA / ACCESS Newswire / August 3, 2026 / Avidbank Holdings, Inc. (the "Company") (NASDAQ:AVBH), the holding company for Avidbank, a California state-chartered bank (the "Bank" or "Avidbank"), today announced the appointment of Jonathan M. Dale (JD) as the Bank's President, who will also serve as the Company's President, effective August 3, 2026...
Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026
First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption of the Pivot Pump.
BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula
Retirement of Largest Outstanding Convertible Debt Clears Runway for High-Growth E-Commerce Rollout of a Targeted Stem Cell Platform LAS VEGAS, NV / ACCESS Newswire / August 3, 2026 / BioAdaptives, Inc. (OTCID:BDPT), a developer of natural, science-backed wellness solutions, today announced that the official opening of its commercial order window for XcellaraHeart™, the flagship product in the company's new Xcellara™ cellular wellness line, will take place later this week. Customers and distributors will soon be able to place orders directly through products.xcellara.com...
QSE Closes First Tranche of Private Placement of $5.3 Million and Announces Further Upsize to $6 Million
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2026) - Quantum Secure Encryption Corp. (CSE: QSE) (OTCQB: QSEGF) (FSE: VN80) ("QSE" or the "Company") is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement financing (the "Offering", see news release dated July 10, 2026 and July 24, 2026) by issuing 11,833,456 units (the "Units") at a price of $0.45 per Unit for total proceeds of $5,325,055.20 (the "First Tranche"). Concurrent with the closing of the First Tranche and due to strong investor demand, the Company has further increased the size of the Offering...
Kaplan Fox Urges PicS N.V. (PICS) Investors to Contact the Firm Before the Deadline on August 4, 2026
New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PicS N.V. ("PicS" or the "Company") (NASDAQ: PICS) on behalf of all persons or entities who purchased PicS Class A common stock in and/or traceable to PicS' initial public offering ("IPO") on or around January 30, 2026...
Unhappy With The $35.00 Per Share Buyout Price? Contact Kaskela Law to Discuss Your Legal Rights and Options with Respect to the Buyout - DSGR
PHILADELPHIA, Aug. 3, 2026 /PRNewswire/ -- Litigation firm Kaskela Law is investigating the sufficiency of the Distribution Solutions Group, Inc. (NASDAQ: DSGR) ("DSG") shareholder buyout proposal to determine whether DSG stockholders may be able to obtain a higher price for their shares. Additional information available at: https://kaskelalaw.com/case/dsg/ On July 16, 2026, DSG reported that it had agreed to be acquired by private equity firm LKCM Headwater Investments ("LKCM Headwater") at a price of $35.00 per share in cash...
FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection
Acurx has received FDA guidance in meeting minutes from a July 13, 2026 Type C Meeting to discuss ibezapolstat's (IBZ) Phase 3 clinical program, including the potential to submit an NDA (New Drug Application) based on a single Phase 3 trial and a clinical trial design intended to support indications for both treatment and reduction of recurrence of Clostridioides difficile infection (CDI) FDA stated that it is open to further discussion on the totality of evidence from the clinical development program at a pre-NDA meeting after completion of a single Phase 3 trial and any other clinical trials conducted prior to the pre-NDA meeting, particularly if the clinical efficacy results are robust Additionally, the Agency agreed that a successful clinical outcome from a single IBZ-ASPIRE Phase 3 trial, supported by the open-label IBZ-PATHFINDER Phase 2 trial in multiply-recurrent CDI (rCDI) will allow NDA filing for both the acute treatment and the reduction of recurrence of CDI Trial start-up activities for the IBZ-PATHFINDER ground-breaking clinical trial in patients with rCDI have been initiated with patient enrollment to begin in the next few months Acurx is well positioned to commence its international Ph3 IBZ-ASPIRE trial, subject to funding availability Acurx has previously been granted FDA QIDP and Fast-Track Designation and has received SME (Small and Medium-sized Enterprise) designation by the EMA STATEN ISLAND, N.Y., Aug. 3, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced the successful outcome of a Type C Meeting conducted with FDA on July 13, 2026 to discuss ibezapolstat's Phase 3 clinical program and scope of its planned NDA...
Broadcom Inc. to Announce Third Quarter Fiscal Year 2026 Financial Results on Wednesday, September 2, 2026
PALO ALTO, Calif., Aug. 3, 2026 /PRNewswire/ -- Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its third quarter fiscal year 2026 financial results and business outlook on Wednesday, September 2, 2026 after the close of the market...
TNL Mediagene Establishes Special Committee to Evaluate Strategic Alternatives, Engages Imperial Capital as Financial Advisor to Pursue Strategic Alternatives to Maximize Shareholder Value
TNL Mediagene's Board of Directors has established a special committee of independent directors to evaluate, and make recommendations to the Board regarding, potential strategic transactions and alternatives available to the Company. The special committee is composed solely of independent directors - Priscilla Han (Chair), Lauren Zalaznick, and Naoko Okumoto...
GameSquare Expands Premium Gaming IP Portfolio Through Sales Partnership with MEGA
Agreement adds recognized global gaming properties to GameSquare's growing catalog of IP available to brand partners FRISCO, TX / ACCESS Newswire / August 3, 2026 / GameSquare Holdings, Inc. ("GameSquare" or the "Company") (NASDAQ:GAME), a next-generation media, entertainment, technology and digital native treasury company, today announced a strategic partnership with MEGA Advanced Ltd. ("MEGA"), owner and operator of the Esports Awards and The Mobies, The Mobile Awards...
Granite Point Mortgage Trust Inc. Announces Refinance of Legacy CLO Assets, Extension and Upsize of JPMorgan Repurchase Facility
NEW YORK--(BUSINESS WIRE)--Granite Point Mortgage Trust Inc. Announces Refinance of Legacy CLO Assets, Extension and Upsize of JPMorgan Repurchase Facility.
Archer's Midnight Completes City-to-City Flights in California Ahead of White House's eIPP
SAN JOSE, Calif.--(BUSINESS WIRE)---- $ACHR #Archer--Archer Aviation (NYSE: ACHR) today announced the completion of a piloted roundtrip journey with its all-electric Midnight aircraft on July 30th, departing from Salinas Municipal Airport and landing at Monterey Regional Airport before making the return flight. Archer worked closely with the FAA to execute this piloted, round trip inter city flight, a major step toward launching Midnight operations under the White House's eIPP program later this year. Midnight c...
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin's Lymphoma
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and autoimmune diseases, today announced the activation of a third clinical site for its ongoing STARLIGHT-1 Phase I/II clinical trial evaluating EB103, a CD19-Redirected ARTEMIS T-cell therapy, in patients with relapsed or refractory (“R/R”) B-cell non-Hodgkin's lymph...
Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (“Spruce Biosciences” or “Spruce”) (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointment of Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development, effective today. Dr. Cohen Pfeffer brings more than a decade of biopharmaceutical industry experience spanning c...
Hadron Energy Announces Date for Q2 2026 Financial and Business Updates
NEW YORK--(BUSINESS WIRE)--Hadron Energy, Inc. (Nasdaq: HDRN) (“Hadron,” or “the Company”), an advanced nuclear micro modular reactor (MMR) developer, today announced that it will release its financial results for the second quarter ended June 30, 2026 though the filing of its Form 10-Q and will provide a CEO Letter to Stockholders after market close on Wednesday, August 12th, 4:05pm ET.The Form 10-Q will be made available through the SEC's EDGAR (Electronic Data Gathering, Online Real-Time) sys...
Hess Midstream LP Reports Estimated Results for the Second Quarter of 2026
HOUSTON--(BUSINESS WIRE)---- $HESM--Hess Midstream LP (NYSE: HESM) (“Hess Midstream” or the “Company”) today reported second quarter 2026 net income of $173.7 million compared with net income of $179.7 million for the second quarter of 2025. After deduction for noncontrolling interests, net income attributable to Hess Midstream was $96.4 million, or $0.75 basic earnings per Class A share, compared with $0.74 basic earnings per Class A share in the second quarter of 2025. Hess Midstream generated Adjusted...
Upstart Publishes July 2026 Originations and Latest UMI
BURLINGAME, Calif.--(BUSINESS WIRE)--Upstart Publishes July 2026 Originations and Latest UMI.
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.09 Per Share for August 2026
HOUSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.09 per share for August 2026. This distribution is payable to common stockholders on August 31, 2026 (as outlined in the table below).
EVE AIR MOBILITY ACHIEVES FIRST TRANSITION FLIGHT MILESTONE, ADVANCING EVTOL PROGRAM TOWARD WING-BORNE FLIGHT
The flight is the first time that the aircraft's pusher propulsion system is activated while in the air and it confirms the key features of Eve's eVTOL design. MELBOURNE, Fla.
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
INDIANAPOLIS, Aug. 3, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to olomorasib as a monotherapy for the treatment of adult patients with advanced pancreatic cancer who have received at least one prior systemic therapy and have a KRAS G12C mutation, as determined by an FDA-approved test. Olomorasib is an investigational, potent and highly selective next-generation inhibitor of KRAS G12C...
Target Hospitality Announces Second Quarter 2026 Earnings Release and Conference Call Schedule
THE WOODLANDS, Texas, Aug. 3, 2026 /PRNewswire/ -- (PRNewswire) – Target Hospitality Corp. ("Target Hospitality", "Target" or the "Company") (NASDAQ: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today announced that it will release its second quarter 2026 financial results before the market opens on Monday, August 10, 2026. The Company has also scheduled a conference call for Monday, August 10, 2026, at 9:00 am Eastern Time (8:00 am Central Time) to discuss the results...
Nexera Enters into Letter of Intent for Exclusive Distribution Rights to Darknet Intelligence Platform for Data Centers
LOI contemplates exclusive worldwide rights to market, promote, resell and distribute Nebo Holdings Limited's Preempt OSINT platform to operators of data centers
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson
Tyson Foods Third Quarter 2026 Financial Results Available on the Company's Investor Relations Website
SPRINGDALE, Ark., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN) today announced its third quarter 2026 financial results through an earnings release available on the company's Investor Relations website at https://ir.tyson.com. Management will host a conference call and webcast beginning at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). The earnings release will be furnished with the Securities and Exchange Commission (SEC) on a Form 8-K...
Curium Announces Definitive Agreement to Merge with Lantheus
BOSTON and BEDFORD, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Curium™, a leading, global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that improve the way cancer is diagnosed and treated, and Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), today announced that Curium US Holdings LLC (“Curium US”) and Lantheus have entered into a definitive agreement under which Lantheus, a leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, will merge with a wholly-owned subsidiary of Curium US...
Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine
DALLAS--(BUSINESS WIRE)--Open Medicine AI is launched as separate entity by Lantern Pharma.
A Brand New Record: Cinemark Achieves Biggest Domestic Weekend Box Office of All Time as Spider-Man: Brand New Day Delivers the Company's Highest Grossing Single-Title, Three-Day Domestic Opening
PLANO, Texas--(BUSINESS WIRE)-- #Cinemark--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that July 31 through August 2 was the biggest domestic weekend box office of all time for the company, propelled by the sensational opening of Spider-Man: Brand New Day, with additional contribution from The Odyssey's strong holdover performance. Additionally, the web-slinging success of Spider-Man: Brand New Day delivered Cine...
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Bombardier to Showcase its Exquisite Challenger 3500 at LABACE 2026 as Part of Extensive Multi-City Latin American Tour
MONTREAL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Bombardier announced today its industry-leading Challenger 3500 will be on display at the Latin American Business Aviation Conference & Exhibition 2026 (LABACE) Aug. 4–6 at Campo de Marte Airport in São Paulo, revealing its impressive design and performance attributes for clients in region...
Crescent Biopharma Announces Grants of Inducement Awards
WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 19,425 shares of the Company's ordinary shares to one non-executive employee as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on July 31, 2026 and were material to the employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4)...
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
Dr. Mehmud's appointment further aligns the scientific, clinical, regulatory and operational leadership of Antev Dr. Mehmud's appointment further aligns the scientific, clinical, regulatory and operational leadership of Antev
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, August 13, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. During the call, Donn Casale, President and Chief Executive Officer, will outline the Company's updated strategic priorities and report second quarter 2026 financial results...
Navigator Gas Announces Signing of $121.8 Million Financing for Two Newbuild Ammonia Carriers in Navigator Amon Joint Venture
LONDON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (“Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world's largest fleet of handysize liquefied gas carriers, is pleased to announce that on July 31, 2026, subsidiaries of Navigator Amon Shipping AS, our joint venture with Amon Maritime, (the “Borrowers”), entered into a senior secured post-delivery term loan (the “Facility Agreement”) with ING Bank N.V., London Branch, Société Générale and Oversea-Chinese Banking Corporation Limited (together, the “Lenders”), to finance the delivery of two 51,350 cubic metre capacity ammonia fuelled liquefied ammonia carriers which will also be capable of carrying liquefied petroleum gas (the “Newbuild Vessels”), and which are currently under construction in China...
Hydrofarm Completes Sale of Aurora Peat Products and Launches Project Agility to Scale Its Logistics Services Platform
SHOEMAKERSVILLE, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) (“Hydrofarm” or the “Company”), today announced that it has completed the sale of Aurora Peat Products ULC (“Aurora Peat”) to Raven Holdings LLC, a private company, for total consideration of $16 million, a portion of which is represented by a promissory note in the amount of $5 million...
Lindblad Expeditions Holdings, Inc. Reports 2026 Second Quarter Financial Results
Second Quarter 2026 Highlights: Total revenue increased 19% to $199.2 million Net loss available to stockholders improved $8.3 million to $1.4 million Adjusted EBITDA increased 31% to $32.5 million Lindblad segment net yield per available guest night increased 4% to $1,294 Occupancy increased to 91% from 86% NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Lindblad Expeditions Holdings, Inc. (NASDAQ: LIND; the "Company" or "Lindblad"), a global provider of expedition cruises and adventure travel experiences, today reported financial results for the second quarter ended June 30, 2026. Natalya Leahy, Chief Executive Officer, said "Our second-quarter results once again demonstrate the strength of our strategy and the focused execution of our team...
HUB Security Regains Full Compliance with Nasdaq Listing Requirements
Nasdaq letter confirms that HUB Security has satisfied the applicable continued-listing requirement and closed the matter Nasdaq letter confirms that HUB Security has satisfied the applicable continued-listing requirement and closed the matter
NovaRed Mining to Evaluate Iron Carbonate-Silica Alteration Zones on the Plume Grid, Wilmac Copper-Gold Project
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2026) - NovaRed Mining Inc. (CSE: NRED) (OTCQB: NREDF) ("NovaRed" or the "Company") is pleased to report the interpretation of two zones of iron carbonate-silica alteration previously mapped on the Plume grid of its Wilmac Copper-Gold Project (the "Project"). Government geologists mapped the two zones in 2009; they cover approximately 115 hectares and 133 hectares...
DSGR Investors Have Opportunity to Join Distribution Solutions Group, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $DSGR--DSGR Investors Have the Opportunity to Join Investigation of Distribution Solutions Group, Inc. with the Schall Law Firm.
Krispy Kreme® Appoints Suk Nicholas as Chief Commercial Officer and Lori Suess as Chief People Officer
CHARLOTTE, N.C.--(BUSINESS WIRE)--Krispy Kreme, Inc. (NASDAQ: DNUT) (“Krispy Kreme” or the “Company”) today announced the appointment of Suk Nicholas as Chief Commercial Officer and Lori Suess as Chief People Officer, effective August 3, 2026. In the newly created role of Chief Commercial Officer, Ms. Nicholas will join Krispy Kreme's Global Leadership Team and lead the Company's fresh delivery business in the U.S. and internationally. She will oversee the development and execution of enterpris...
SOLOWIN HOLDINGS' (NASDAQ: AXG) Subsidiary AX Coin Bahrain Receives Sharia Certification for AXBHD Stablecoin
MANAMA, Bahrain, Aug. 03, 2026 (GLOBE NEWSWIRE) -- AX Coin Bahrain B.S.C. Closed (“AX Coin Bahrain”), the regulated stablecoin issuer of Solowin Holdings (Nasdaq: AXG), today announced a historic milestone as its stablecoin framework, the AXBHD stablecoin, and supporting documentation have completed a formal Sharia review. This achievement distinguishes AXBHD as the first central bank regulated stablecoin to receive this certification, which was conducted by Shariyah Review Bureau W.L.L. (“SRB”), a Sharia advisory and audit firm licensed by the Central Bank of Bahrain...
BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET
PALO ALTO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its second quarter 2026 financial results and business update after the market closes on Monday, August 10, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day...